Nivolumab Drug Substance from Canada
Nivolumab drug substance is bulk PD-1 blocking antibody for melanoma and lung cancer therapy. HTS 3002.13.0090 for unmixed immunological products via biotech processes. Meets definition of antibody regulating immunology.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Drug substance vs product distinction critical for classification
• Advance CBP notification for values >$2500
• Stability data prevents retest upon arrival